$IBP

IBP (IBP) Q2 2026 Earnings Call Transcript

Installed Building Products (IBP) reported Q2 2026 net revenue of $777.8 million, up 2.3%, with adjusted gross margin at 33.3% and adjusted EBITDA of $130.9 million. Installation revenue was $710.7 million, down 0.7%, while Other segment revenue rose to $67.1 million. The company repurchased $76.2 million of shares and declared a $0.39 dividend.

Original reporting
Published Aug 13, 2026, 5:45 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Aug 13, 2026, 6:06 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
IBP (IBP) Q2 2026 Earnings Call Transcript — source image
Decision brief

The 30-second read

$IBPNeutralMed
01

Why it matters

Key decision inputs for traders are the quantified margin headwinds (fuel and medical insurance), the segment mix shift toward heavy commercial, and updated full-year items (amortization guidance, tax rate) plus ongoing repurchase capacity.

02

Market read

Traders can update expectations for 2H margins and growth mix based on heavy commercial momentum, residential softness, and cost-driven margin pressure.

03

What to watch

Fuel and medical insurance are cited as margin headwinds; traders may also watch whether spray foam material cost inflation is truly being passed through sustainably.

Relevance 8/10Novelty 8/10Timing: post-earnings call, Aug. 13 article referencing Aug. 6 Q2 results

Background

The piece is a transcript-style summary of Installed Building Products’ Q2 2026 earnings call, covering revenue, margins, segment trends, acquisitions, and capital return.

Company-level read

Ticker impact

$IBPNeutralMedium confidence
Context

Installed Building Products reported Q2 2026 results with net revenue $777.8M, adjusted gross margin 33.3%, and a $76.2M share repurchase.

Expected impact

Near-term volatility likely around margin headwinds versus commercial strength and capital return updates.

Evidence & confidence

The article provides multiple quantified operating drivers (fuel, medical insurance, same-branch sales, EBITDA margin) plus capital allocation (repurchases, dividend) that can shift trader expectations for 2H margins and growth.

Market effects

Highlights ongoing insulation/building-products demand bifurcation, with heavy commercial strength offsetting residential softness.

Notes South Census region is ~60% of multi-family revenue, implying regional demand sensitivity for 2H.

Limited direct global linkage; primarily US construction and building-material cost dynamics (fuel, medical insurance, spray foam).

Counterpoint

Commercial strength may not fully offset residential weakness if affordability-driven single-family declines persist into 2H.

Key entities

  • Installed Building Products, Inc.

    IBP, the subject issuer, reported Q2 2026 financial results and discussed segment performance, margin drivers, acquisitions, and capital allocation.

  • Jeffrey Edwards

    CEO who framed residential challenges and cited multifamily inflection in June and July.

  • Michael Miller

    CFO who attributed gross margin decline to fuel expense and EBITDA margin impact to medical insurance costs.

Related articles

$IBPMed

Installed Building Products, Inc. (IBP): Results of Operations and Financial Condition

Installed Building Products, Inc. (IBP) filed an SEC Form 8-K — Results of Operations and Financial Condition. EX-99.1 2 ibp-q22026earningsrelease.htm EX-99.1 Document INSTALLED BUILDING PRODUCTS REPORTS SECOND QUARTER 2026 RESULTS; DECLARES REGULAR QUARTERLY CASH DIVIDEND Columbus, Ohio, August 6, 2026, Installed Building Products, Inc. (the "Company" or "IBP") (NYSE: IBP), an industry-l

$LRCXMedAI 8/10

Lam Research Corp (LRCX) Stock News & Articles

The article discusses ACM Research, a $5.1 billion cleaning-tool maker, and notes its results as a read on whether Chinese fabs are still buying despite export controls. It cites ACM Research Q4 2026 EPS of $1.82 (vs $1.68 est) and revenue of $6.72B (vs $6.67B est). It also mentions read-throughs to Lam Research and Applied Materials, and Lam Research’s guidance for a September-quarter revenue of $8.10B.

$BNMed

Brookfield Corporation Q2 2026 Earnings Call Summary

Brookfield Corporation reported Q2 2026 distributable earnings before realizations up 15%, citing record fundraising of $98B and $100B capital deployment. Management highlighted AI infrastructure demand driven by power constraints, nuclear expansion via Westinghouse, and credit/insurance platform gains from Just Group and the Oaktree merger. It also discussed a $100B DOE partnership and plans to grow wealth insurance assets above $300B by decade end.

$CMRCMedAI 8/10

Commerce.com (CMRC) Q2 2026 Earnings Call Transcript

Commerce.com (CMRC) reported Q2 2026 revenue of $84.5M, up 0.1% year over year, and non-GAAP operating income of $8.1M. GMV rose 14% to $8.8B, ARR was $360.5M, and NRR improved to 95.8%. It cut FY2026 revenue guidance to $336.5M-$344.5M and non-GAAP operating income to $28M-$34M at midpoint.

$IPWRMed

Ideal Power Inc. Q2 2026 Earnings Call Summary

Ideal Power Inc. reported Q2 2026 progress tied to 800-volt DC adoption in AI data centers. Its sales funnel rose to over $400 million. The company expects prototype B-TRAN-enabled SSCBs for 800-volt customers in Q4 2026, with initial low-volume orders then. 2026 cash burn is projected at $10.3M to $10.5M after a May $27.7M net raise.